Gregory L. Shiferman serves as Executive at Sage Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Gregory L. Shiferman has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 6, 2026 involved receiving (via award) 100,000 shares valued at $0.
Gregory L. Shiferman currently holds 100,000 shares of Sage Therapeutics, Inc. (SAGE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gregory L. Shiferman has been a net neutral trader of SAGE stock. They have purchased $0 and sold $0 worth of shares.
Gregory L. Shiferman's most recent insider trade was on Jan 6, 2026, when they sold 100,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 31, 2025 | SAGE | $0 | Tender | 7,215 | $N/A | Discretionary |